Breaking News, Financial News

Financial Report: BASi

Restructuring charges impact results

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi   3Q Revenues: $7.2 million (-15%) 3Q Loss: $704,000 (earnings were $418 million 3Q11) YTD Revenues: $21.7 million (-13%) YTD Loss: $4.1 million (earnings were $1.2 million YTD11) Comments: Service revenue was $5.2 million in the quarter (-23%). Product revenue was $2.0 million (+14%). Restructuring charges were $623,000 in the quarter and $687,000 YTD....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters